Akebia continues to publish important, clinically relevant data to further physicians’ understanding of Vafseo® ...

(Vienna, Austria, Thursday 5 June 2025) A major international study, being presented today at the 62nd ERA Congress, reveals that the long-accepted survival advantage of deceased-donor kidney ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.

The Hindu will host a webinar titled, ‘Will new MBBS curriculum equip doctors for today’s challenges?’, on June 7, at 5:00 ...

At an event in Dunedin to celebrate the Otago Medical School’s 150th anniversary, Chancellor Trish Oakley announced alumni Dame Margaret Sparrow, Professor Dinah Reddihough, Associate Professor Jioji ...

Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.

Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 and June 3 was host to the Poster Session: Genitourinary Cancer - Kidney and ...